Dr. Rohan Gupta, DO
What this data tells you about Dr. Gupta
Dr. Rohan Gupta is an internal medicine specialist in Burleson, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 113,783 Medicare services across 2,113 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gupta received a total of $66,774 from 53 pharmaceutical and/or device companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 39,750 | $1 | $3 |
| Filgrastim injection (Nivestym) for white blood cells | 29,760 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 27,150 | $0 | $5 |
| Dexamethasone injection (steroid) | 4,329 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,800 | $1 | $52 |
| Hospital follow-up visit, high complexity | 1,129 | $93 | $250 |
| Office visit, established patient, complex (40-54 min) | 1,073 | $137 | $350 |
| Injection, leucovorin calcium, per 50 mg | 924 | $3 | $15 |
| Injection of additional new drug or substance into vein | 889 | $12 | $70 |
| Injection, fluorouracil, 500 mg | 660 | $2 | $5 |
| Flow cytometry, additional marker | 648 | $19 | $125 |
| Administration of chemotherapy into vein, 1 hour or less | 576 | $102 | $412 |
| Office visit, established patient (30-39 min) | 377 | $93 | $275 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 340 | $23 | $100 |
| COVID-19 test, self-administered | 336 | $12 | $30 |
| Injection, zoledronic acid, 1 mg | 301 | $7 | $300 |
| Hospital follow-up visit, moderate complexity | 268 | $62 | $175 |
| Drug injection, under skin or into muscle | 250 | $11 | $60 |
| Administration of additional new drug or substance into vein, 1 hour or less | 215 | $50 | $202 |
| Administration of chemotherapy into vein, each additional hour | 204 | $22 | $93 |
| Injection, diphenhydramine hcl, up to 50 mg | 193 | $1 | $10 |
| Initial hospital admission, high complexity | 190 | $133 | $500 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 158 | $48 | $160 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 119 | $49 | $190 |
| Ct scan of chest with contrast | 110 | $48 | $401 |
| CT scan of abdomen and pelvis with contrast | 97 | $165 | $681 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 89 | $105 | $450 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 86 | $133 | $450 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 83 | $1,160 | $4,069 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 76 | $1 | $5 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 72 | $37 | $120 |
| Telephone medical discussion with physician, 21-30 minutes | 62 | $84 | $300 |
| Initial hospital admission, moderate complexity | 53 | $101 | $350 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 50 | $16 | $60 |
| Office visit, established patient (20-29 min) | 47 | $64 | $175 |
| Infusion into a vein for hydration, 31-60 minutes | 41 | $23 | $155 |
| Injection of drug or substance into vein | 39 | $29 | $145 |
| Comprehensive metabolic blood panel | 35 | $10 | $50 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 35 | $16 | $60 |
| Infusion, normal saline solution , 1000 cc | 35 | $2 | $20 |
| Flow cytometry technique for dna or cell analysis, first marker | 29 | $57 | $200 |
| New patient office visit, complex (60-74 min) | 26 | $172 | $500 |
| New patient office visit (45-59 min) | 25 | $125 | $400 |
| Advance care planning consultation, first 30 min | 22 | $62 | $250 |
| Ct scan of abdomen and pelvis without contrast | 16 | $77 | $338 |
| Chronic care management, first 20 min/month | 16 | $49 | $161 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (48%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for internal medicine in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gupta is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with speaking/promotional industry engagement in the top 2% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gupta experienced with iron infusion (injectafer)?
Does Dr. Gupta receive payments from pharmaceutical companies?
How do Dr. Gupta's costs compare to other internal medicine physicians in Burleson?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology